US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
By Dennis Thompson HealthDay ReporterTUESDAY, March 10, 2026 (HealthDay News) — An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed.
More than three-quarters of lupus patients taking obinutuzumab (Gazv… [3459 chars]
Source: U.S. News & World Report | Published: 2026-03-10T10:15:00Z
Credit: U.S. News & World Report








